Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Arnott

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Gastroenterology & Hepatology|June 1, 2000
Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injuryI D Arnott, S Ghosh
European Journal of Gastroenterology & Hepatology|May 20, 1999
The spectrum of ischaemic colitisI D Arnott, S Ghosh, A Ferguson
Scandinavian Journal of Gastroenterology|January 6, 2001
Abnormal intestinal permeability predicts relapse in inactive Crohn diseaseI D Arnott, K Kingstone, S Ghosh
The American Journal of Gastroenterology|November 30, 2000
Administration of infliximab in Crohn's disease does not deplete complement components C3 and C4I D Arnott, A Shand, S Ghosh
Scottish Medical Journal|January 5, 2002
Frequency of continuing mucosal inflammation in clinically inactive Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
European Journal of Gastroenterology & Hepatology|April 11, 2001
Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
Digestive Diseases and Sciences|April 3, 2001
Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
Alimentary Pharmacology & Therapeutics|September 21, 2001
Clinical use of Infliximab in Crohn's disease: the Edinburgh experienceI D Arnott, D McDonald, A Williams, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' replyG R Jones, N A Kennedy, C W Lees, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2018
Capsule endoscopy in suspected small bowel Crohn's disease - Is it worth repeating a negative study?A R Robertson, D E Yung, I D Arnott, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Gastroenterology & Hepatology|June 1, 2000
Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injuryI D Arnott, S Ghosh
European Journal of Gastroenterology & Hepatology|May 20, 1999
The spectrum of ischaemic colitisI D Arnott, S Ghosh, A Ferguson
Scandinavian Journal of Gastroenterology|January 6, 2001
Abnormal intestinal permeability predicts relapse in inactive Crohn diseaseI D Arnott, K Kingstone, S Ghosh
The American Journal of Gastroenterology|November 30, 2000
Administration of infliximab in Crohn's disease does not deplete complement components C3 and C4I D Arnott, A Shand, S Ghosh
Scottish Medical Journal|January 5, 2002
Frequency of continuing mucosal inflammation in clinically inactive Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
European Journal of Gastroenterology & Hepatology|April 11, 2001
Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
Digestive Diseases and Sciences|April 3, 2001
Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's diseaseI D Arnott, H E Drummond, S Ghosh
Alimentary Pharmacology & Therapeutics|September 21, 2001
Clinical use of Infliximab in Crohn's disease: the Edinburgh experienceI D Arnott, D McDonald, A Williams, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' replyG R Jones, N A Kennedy, C W Lees, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2018
Capsule endoscopy in suspected small bowel Crohn's disease - Is it worth repeating a negative study?A R Robertson, D E Yung, I D Arnott, et al.
Pageof 3